S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave

Beauty Health (SKIN) Stock Price, News & Analysis

$3.27
-0.16 (-4.66%)
(As of 04/19/2024 ET)
Today's Range
$3.22
$3.48
50-Day Range
$2.80
$4.53
52-Week Range
$1.35
$13.90
Volume
1.63 million shs
Average Volume
1.60 million shs
Market Capitalization
$403.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

Beauty Health MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.92 Rating Score
Upside/​Downside
98.8% Upside
$6.50 Price Target
Short Interest
Healthy
13.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.04mentions of Beauty Health in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.10) to $0.02 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.33 out of 5 stars

Medical Sector

290th out of 911 stocks

Surgical & Medical Instruments Industry

36th out of 97 stocks

SKIN stock logo

About Beauty Health Stock (NASDAQ:SKIN)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN Stock Price History

SKIN Stock News Headlines

Did you know you can now trade Bitcoin in your regular brokerage account?
You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!
Did you know you can now trade Bitcoin in your regular brokerage account?
You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!
See More Headlines
Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
4/20/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SKIN
Fax
N/A
Employees
881
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$23.00
Low Stock Price Target
$2.50
Potential Upside/Downside
+98.8%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
12 Analysts

Profitability

Net Income
$-100,120,000.00
Pretax Margin
-25.60%

Debt

Sales & Book Value

Annual Sales
$398 million
Book Value
$0.48 per share

Miscellaneous

Free Float
71,958,000
Market Cap
$403.62 million
Optionable
Optionable
Beta
1.01
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Marla Malcolm Beck (Age 54)
    President, CEO & Director
    Comp: $31.49k
  • Mr. Daniel Copell Watson (Age 61)
    Chief Revenue Officer
    Comp: $777.36k
  • Mr. Michael P. Monahan (Age 52)
    Chief Financial Officer
  • Ms. Sheri Lewis (Age 58)
    Chief Supply Chain & Operations Officer
  • Eduardo Rodriguez
    Senior Director of M&A and Investor Relations
  • Mr. Paul Bokota
    VP & General Counsel
  • Ms. Celeste Ortiz
    Chief Human Resources Officer
  • Mr. Mingo Ku
    President of APAC
  • Mr. Jon Arnold
    President of EMEA

SKIN Stock Analysis - Frequently Asked Questions

Should I buy or sell Beauty Health stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beauty Health in the last year. There are currently 3 sell ratings, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" SKIN shares.
View SKIN analyst ratings
or view top-rated stocks.

What is Beauty Health's stock price target for 2024?

12 brokerages have issued 1-year price objectives for Beauty Health's shares. Their SKIN share price targets range from $2.50 to $23.00. On average, they predict the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 98.8% from the stock's current price.
View analysts price targets for SKIN
or view top-rated stocks among Wall Street analysts.

How have SKIN shares performed in 2024?

Beauty Health's stock was trading at $3.11 at the beginning of the year. Since then, SKIN shares have increased by 5.1% and is now trading at $3.27.
View the best growth stocks for 2024 here
.

When is Beauty Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our SKIN earnings forecast
.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) announced its earnings results on Tuesday, March, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.04. The company had revenue of $96.80 million for the quarter, compared to analyst estimates of $87.22 million. Beauty Health had a negative net margin of 25.65% and a negative trailing twelve-month return on equity of 18.85%. Beauty Health's revenue for the quarter was down 1.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.03 earnings per share.

What ETF holds Beauty Health's stock?

Ranger Equity Bear ETF holds 150,000 shares of SKIN stock, representing -1.00% of its portfolio.

What guidance has Beauty Health issued on next quarter's earnings?

Beauty Health updated its first quarter 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $77.0 million-$83.0 million, compared to the consensus revenue estimate of $85.5 million.

Who are Beauty Health's major shareholders?

Beauty Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include 180 Wealth Advisors LLC (0.07%). Insiders that own company stock include Brent L Saunders, Doug K Schillinger and Michael P Monahan.
View institutional ownership trends
.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SKIN) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners